KBL MERGER CORP. IV
Completed 2020-11-06- CIK 1690080
- KBLM
- Now ATNF
- IPO 2017-06-02
- $10.3M trust
- 761 filings
Successfully merged with 180 Life Corp. (f/k/a 180 Life Sciences Corp.) • Now trading as ATNF
- IPO Size
- $119M
- raised at the IPO
- Trust
- $10.3M
- as of 2020-09-30
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2017
- year it listed
Filings, by quarter
761 filings over 41 quarters; violet bars carry a milestone
- 16 Q4: 2 filings
- 17 Q1: 6 filings
- 17 Q2: 33 filings
- 17 Q3: 2 filings
- 17 Q4: 3 filings
- 18 Q1: 4 filings
- 18 Q2: 2 filings
- 18 Q3: 2 filings
- 18 Q4: 5 filings
- 19 Q1: 12 filings
- 19 Q2: 17 filings
- 19 Q3: 14 filings
- 19 Q4: 11 filings
- 20 Q1: 13 filings
- 20 Q2: 8 filings
- 20 Q3: 11 filings
- 20 Q4: 48 filings
- 21 Q1: 15 filings
- 21 Q2: 11 filings
- 21 Q3: 43 filings
- 21 Q4: 25 filings
- 22 Q1: 10 filings
- 22 Q2: 40 filings
- 22 Q3: 12 filings
- 22 Q4: 15 filings
- 23 Q1: 10 filings
- 23 Q2: 24 filings
- 23 Q3: 30 filings
- 23 Q4: 18 filings
- 24 Q1: 27 filings
- 24 Q2: 11 filings
- 24 Q3: 8 filings
- 24 Q4: 29 filings
- 25 Q1: 26 filings
- 25 Q2: 40 filings
- 25 Q3: 62 filings
- 25 Q4: 51 filings
- 26 Q1: 15 filings
- 26 Q2: 25 filings
- 26 Q3: 20 filings
- 26 Q4: 1 filing
- S-1 filed 16 Q4
- IPO 17 Q2
- Definitive agreement 19 Q3
- Completed 20 Q4
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
About
KBL Merger Corp. IV is a blank-check company formed to acquire one or more operating businesses. It intends to focus on healthcare and related wellness, while retaining the ability to consider businesses in other industries.
Investment Focus
Healthcare, Wellness
Key Information
As the filings state it
- IPO Date
- 2017-06-02
- Total Redemptions
- $119M
- SIC
- 6770
- Completion Date
- 2020-11-06
- Merger Target
- 180 Life Corp. (f/k/a 180 Life Sciences Corp.)
- SPAC Ticker
- KBLM
- Merged Ticker
- ATNF
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The team is led by CEO and director Marlene Krauss, who has extensive healthcare investing and operating experience and previously led three SPACs, and COO and director nominee Joseph A. Williamson, a longtime healthcare operator and executive. Its board nominees include experienced finance and healthcare investors George Hornig, Andrew Sherman, and Sherrill Neff.